Pharma Execs: Veteran Developers Make Ideal Companion-Diagnostics Partners
This article was originally published in The Pink Sheet Daily
Executive Summary
A preferred diagnostics partner must demonstrate a proven record for regulatory approval and gaining reimbursement, as well as a capacity to pursue global commercialization with manufacturing and distribution capabilities to support those efforts, execs said at the Next Generation Dx Summit.